Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.

Asia Healthcare Holdings (AHH), backed by GIC and TPG, will invest INR 400 crore over five years to grow its nephrology and urology specialty hospital network from 7 to 20 locations.

Focused on Tier 2 cities such as Patna and Bhubaneshwar, the expansion aims to elevate specialty care access beyond metropolitan centers. Flagship hospitals in Hyderabad and Chennai serve as models for integrated care with robust renal and urinary health services. AHH plans to enhance diagnostic capabilities, technology adoption, and specialist training in line with India’s rising burden of kidney disease.